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Abstract 
Introduction: Diabetic dyslipidemia is the major cause for higher cardiovascular morbidity and mortality. Insulin resistance has 
been shown to be important in regulating the concentrations of lipoproteins and results in predominant lipid abnormalities.  
Methodology: Prospective, cross sectional study was undertaken to know the prevalence of dyslipidemia among ambulatory 
patients with type 2 diabetes mellitus at Diabetes Centre, KLES Prabhakar Kore Hospital & MRC, Belgaum,Karnataka. The 
details history regarding demographic profile, anthropometric measurements, and life style related factors (tobacco and 
alcohol consumption) were documented in pretested proforma. Fasting venous sample was collected for measurement of 
serum lipids and glucose. We referred to National Cholesterol Education Programme (NCEP) -Adult Treatment Panel (ATP) III 
guidelines for lipid profile analysis. 
Results: A total of 1112 patients with type 2 diabetics without obvious CVD, renal, hepatic or PVD problems were studied. We 
found that nearly 80% of the subjects had at least one abnormal lipid parameter. 58.6% males and 41.4% females found to be 
dyslipidemic (p=0.000). Further, the prevalence of isolated hypercholesterolaemia; males (63.4%), females (36.6%), isolated 
hypertriglycerdaemia; males (58.9%), females (41.1%), isolated high LDL; males (56.7%), females (43.3%) and isolated low 
HDL; males (52.7%), females (47.3%) was found. Thus prevalence of fasting isolated abnormal lipid parameters was 
significantly higher among males with diabetes. 
Conclusion: Many patients with diabetes remain uncontrolled for dyslipidemia. Efforts at screening, treatment and Life style 
modification according to current guidelines would help in reducing CVD morbidity and mortality in diabetes dyslipidemic 
patients. 
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Introduction 
A substantial proportion of patients with type-2 
diabetes have abnormal serum lipid. Insulin resistance 
is not only associated with hyperglycaemia but also 
with disorders of concentration of lipoproteins. Diabetic 
dyslipidemia is a hall mark of metabolic syndrome and 
is believed to play an important role in the 
pathogenesis of atherosclerosis.1-2 Thus it has become 
major cause for higher cardiovascular morbidity and 
mortality. Cardiovascular diseases (CVD) are the most 
prevalent cause of death and disability in both 
developed as well as developing countries.3 South 
Asians around the globe have the highest rates of 
Coronary Artery Disease (CAD).4 According to National 
Commission on Macroeconomics and Health (NCMH), 
a government of India undertaking, there would be 
around 62 million patients with CAD by 2015 in India 
and of these, 23 million would be patients younger than 
40 years of age5. CAD is usually due to atherosclerosis 
of large and medium sized arteries and Diabetic 
dyslipidemia has been found to be one of the most 
important contributing factor6. 
 
Methodology  
A total of 1112 patients with type 2 diabetes 
attending Diabetes Centre, KLES Dr. Prabhakar 
Hospital and Medical Research Centre, Belgaum were 
recruited in this study. Patients with nephropathy, 
hepatic disease, hypothyroidism, Cushing’s disease, 
inherited disorders of lipid metabolism, clinical or ECG 
evidence of CAD, alcoholism, smoking or use of 
medication affecting lipids were excluded. Prospective, 
hospital based cross-sectional study was carried to 
determine the prevalence of lipid disorders among 
ambulatory patients with type 2 diabetes mellitus. The 
study period was from March 2009 to February 2010. 
 A venous blood samples were collected after an 
over night fast for 12-14 hrs. The analysis was carried 
on an automated clinical chemistry analyzer. According 
to National Cholesterol Education Programme (NCEP) 
and Adult Treatment Panel (ATP) III guidelines6-7  the 
lipid profile analysis was done as follows, 
Hypercholesterolaemia– TC > 200 mg/dl, 
Hypertriglycerdaemia – TG > 150 mg/dl, LDL-C > 100 
mg/dl and HDL-C < 40 mg/dl. The statistical analysis 
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was carried out using the SPSS (version 17.0) and 
statistical tool used was Chi-square test. 
Results 
Our study population comprised of total 1112 
subjects (Males: 62.1%, Females: 37.9%) ambulatory 
patients with type 2 diabetes mellitus. By referring to 
standard guidelines of NCEP-ATP III, we found that nearly 
80% of the subjects had at least one abnormal lipid 
parameter. 
 
 
Table No.1 Prevalence of Dyslipidaemia according to gender of subjects 
 
               X2=23.548                                   DF=1                                        P=0.000 
 
 
The prevalence of dyslipidemia was higher among 
males (58.6%) compared to females (41.4%). The 
results were statistically significant (p=0.000). 
 
Table No.2 Age Specific Prevalence of Dyslipidemia among Males 
 
                         X2=3.975                                  DF=2                                       P=0.137 
 
 
We found that prevalence of dyslipidemia 
increases as the age advances among males. The 
prevalence was 80% among > 50 yrs which was 
significantly higher compared to other age groups. The 
results were statistically not significant (p=0.137).
 
 
Table No.3 Age Specific Prevalence of Dyslipidemia among Females 
 
Age Group  
(yrs) 
Total Females Diabetic Dyslipidemia 
subjects 
% 
30-40 138 121 87.6% 
40-50 162 145 89.5% 
> 50 121 102 84.3% 
Total 421 368 87.4% 
 
                                X2= 1.721                                  DF= 2                                       P=0. 423 
 
We found that no significant difference of 
prevalence of dyslipidemia among all age groups of 
females. The results were statistically not significant 
(p=0.423).
 
 
 
 
 
 Group  Males Females Total 
Dyslipidemia 521(58.6%) 368 (41.4%) 889 (79.94%) 
Normolipidemia 170 (76.2 %) 53 (23.8%) 223(20.05%) 
Total 691 (62.1%) 421(37.9%) 1112 
Age Group  
(yrs) 
Total Males Diabetic Dyslipidemia subjects % 
30-40 190 138 72% 
40-50 271 199 73% 
> 50 230 184 80% 
Total 691 521 75.4% 
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Table No.4 Prevalence of Isolated Dyslipidaemia 
 
Dyslipidemia group Males Females Total 
Hypercholesterolemia 170 (63.4%) 98 (36.6%) 268 (30.15%) 
Hypertriglycerdaemia 145 (58.9%) 101 (41.1%) 246 (27.67%) 
High LDL 118 (56.7%) 90 (43.3%) 208 (23.39%) 
Low LDL 88 (52.7 %) 79 (47.3%) 167 (18.78%) 
Total 521(58.6%) 368(41.4%) 889 (79.94%) 
 
      X2=5.292                                   DF=3                                        P= 0.152 
 
The prevalence of isolated hypercholesterolaemia; 
males (63.4%), females (36.6%), isolated 
hypertriglycerdaemia; males (58.9%), females (41.1%), 
isolated high LDL; males (56.7%), females (43.3%) and 
isolated low HDL; males (52.7%), females (47.3%) was 
found. Thus prevalence of fasting isolated abnormal 
lipid parameters was significantly higher among males 
with diabetes. However, the results were statistically 
not significant (p=0.152). 
Discussion 
The study reveals the prevalence of 
hypercholesterolemia, hypertriglycerdaemia and 
abnormally high LDL-C and low HDL-C levels which in 
all age groups. Our results are consistent with the 
previous cross-sectional study conducted by Sawant 
AM et.al among young adult population wherein 
increased prevalence of dyslipidemia in young adults 
was found to be one of the major contributors of CVD.8  
In our study, the high prevalence of 
hypercholesterolemia, hypertriglycerdaemia and low 
HDL, in all age groups among females was a major 
cause of concern. It has been observed that in 
comparison with western population, a relatively lower 
level of cholesterol appears to predispose Indians to 
CAD. 9  Also in a Chennai based hospital study, it was 
shown that around 75% of patients with myocardial 
infarction (MI) had TC levels <200mg/dl indicating that 
the threshold for the TC levels above which it posses a 
risk for CAD is low in Indians.10 We found that the 
crude prevalence of dyslipidemia was higher in men 
than in women. The contributing factor for dyslipidemia 
in our population could be our diet rich in 
carbohydrates.11 High TG levels have been associated 
with increased levels of small dense LDL which are 
considered to be highly atherogenic.12 Increased 
prevalence of low HDL has been reported earlier by 
Enas et.al., who found that only 4% of Asian Indian 
men and 5% Asian Indian women had optimal HDL 
levels.13   Low HDL-C levels are stronger predictor of 
occurrence and reoccurrence of MI and stroke and are 
also associated with premature and severe CAD.14 
Oxidative modification of LDL-C is a key process of 
atherosclerosis and elevated LDL-C has been 
recognized as primary risk factor for CAD by NCEP – 
ATPIII. 15 In our study increased LDL-C has been found 
to be contributing majorly to dyslipidemia irrespective 
of age and gender. Comparing our data with a Turkish 
study conducted on similar lines, lead to the 
observation that in both the studies, prevalence of 
dyslipidemia was more in males but the percentage 
prevalence in our population was higher indicating 
Indians being at higher risk.16 Diet with high fat and 
calorie intake and lack of physical activity would be the 
major culprits of dyslipidemia in our population. 
References have shown that our diets are rich in 
saturated fats. Besides it also involves overcooking of 
food which results in destruction of nutrients like folate, 
deep frying and refrying in the same oil leading to trans 
fatty acids formation which probably contributes to 
increase of Dyslipidemia in our population.17  In addition 
many studies have reported that lipid metabolism could 
by altered by factors such as obesity,18 insulin 
resistance,19 age20 and visceral obesity.21 
Conclusion 
The increasing modernization and adoption of a 
more sedentary lifestyle in rural and urban India has 
taken its toll on the health of the populace, with its 
chronic course, we can expect diabetes and 
dyslipidemia to have a serious adverse impact on the 
life expectancy as well as the quality of life in India. 
Many patients with diabetes remain uncontrolled for 
dyslipidemia. Efforts at screening, treatment and Life 
style modification according to current guidelines would 
help in reducing CVD morbidity and mortality in 
diabetes dyslipidemic patients. A better understanding 
about the cause of a predisposition of Indians to 
become diabetic dyslipidemia will go a long way in 
planning health policy to curb the burden of chronic 
diseases. 
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